The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 5, 1997, Pages 477-478

  Cascinu, S ^a,b   Del Ferro, E ^a   Ligi, M ^a   Graziano, F ^a   Catalano, G ^a  

^a Azienda Ospedaliera Osp S S   (Italy)

^b Ospedale di Muraglia   (Italy)

Author keywords

Elderly patients; Small cell lung cancer; Tenisopide; VM26

Indexed keywords

TENIPOSIDE;

AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HAIR LOSS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG SMALL CELL CANCER; MALE; NAUSEA; THROMBOCYTOPENIA; VOMITING;

AGED; AGED, 80 AND OVER; ALOPECIA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BONE MARROW; CARCINOMA, SMALL CELL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; LEUKOPENIA; LUNG NEOPLASMS; MALE; NAUSEA; NEOPLASM STAGING; REMISSION INDUCTION; SURVIVAL RATE; TENIPOSIDE; THROMBOCYTOPENIA; VOMITING;

EID: 0030769554     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199710000-00008     Document Type: Article

References (13)

1. Teeter SM, Holmes FF, McFarlane MJ. Lung carcinoma in the elderly population: influence of histology on the increase relationship of stage to age. Cancer 1987;60:1331-6.
2. Sheperd FA, Amdemichael E, Evans WK. Treatment of smallcell lung cancer in the elderly. J Am Geriair Soc 1994; 42:6470.
3. Carney DN, Grogan L, Smit EF, Harford P, Berendsen HH, Postmus PE. Single-agent oral etoposide for elderly small-cell lung cancer patients. Sem Oncol 1990; 17:49-53.
4. Bork E, Ersboll J, Domberowsky P, Bergman B, Hansen M, Hansen HH. Teniposide and etoposide in untreated small-cell lung cancer: a randomized study. J Clin Oncol 1991;9:1627-31.
5. Bork E, Hansen M, Dombernowsky P, Hansen PW, Pedersen AG, Hansen HH. Teniposide (VM26), an overlooked highly active agent in small cell lung cancer. Results of a phase II trial in untreated patients. J Clin Oncol 1986;4:524-7.
6. Cemy T, Pedrazzini A, Joss RA, Brunner KW. Unexpected high toxicity in a phase II study of teniposide (VM26) in elderly patients with untreated small-cell lung cancer (SCLC). Eur J Cancer Clin Oncol 1988;24:1791-4.
7. Holoye PY, Winn RJ, Craig K, Ozark W, Camnon MV. Phase II study of teniposide in small-cell bronchogenic carcinoma. ProcAm Soc Clin Oncol 1989;8:243.
8. Giaccone G, Donadio M, Bonardi G, Testore F, Calciati A. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy. J Clin Oncol 1988;6:1264-70.
9. Tummarello D, Isidori P, Pasini F, Cetto G, Cellerino R. Teniposide as single drug therapy for elderly patients affected by smallcell lung cancer. Eur J Cancer 1992;28A:I081-4.
10. Stahel RA, Ginsberg R, Havemann K. Staging and prognostic factors in small-cell carcinoma of the lung. Consensus report. Lung Cancer 1989;5:119-26.
11. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
12. Balducci L, Phillips DM, Davis KM. Systemic treatment of cancer in the elderly. Arch Gerontol Geriatr 1988;7:119-50.
13. Cascinu S, Del Ferro E, Catalano G. Toxicity and therapeutic response to chemotherapy in advanced cancer patients aged 70 years or older. Am J Clin Oncol 1996; 19(4):371-4.